Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Bristol-Myers Higher on Progress With Lymphoma-Drug Trial
By Rob Lenihan
Jun 10, 2021 1:50 PM EDT
Latest News
PRESS RELEASES
Bristol Myers Squibb Announces Dividend
By Business Wire
Jun 17, 2021 4:16 PM EDT
PRESS RELEASES
Exelixis Announces Clinical Trial Collaboration And Supply Agreement With Bristol Myers Squibb To Evaluate XL092 In Combination With Immuno-oncology Therapies In Advanced Solid Tumors
By Business Wire
Jun 14, 2021 8:00 AM EDT
PRESS RELEASES
(Graphic: Bristol Myers Squibb)
By Business Wire
Jun 10, 2021 4:16 PM EDT
INVESTING
Bristol-Myers Higher on Progress With Lymphoma-Drug Trial
By Rob Lenihan
Jun 10, 2021 1:50 PM EDT
PRESS RELEASES
Bristol Myers Squibb To Report Results For Second Quarter 2021 On July 28, 2021
By Business Wire
Jun 10, 2021 7:05 AM EDT
PRESS RELEASES
Bristol Myers Squibb To Take Part In Goldman Sachs 42nd Annual Global Healthcare Conference
By Business Wire
Jun 4, 2021 6:59 AM EDT
INVESTING
Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, and Thermo Fisher
By Alicia Stein
Jun 2, 2021 6:01 PM EDT
PRESS RELEASES
Bristol Myers Squibb To Take Part In Bernstein's 37th Annual Strategic Decisions Conference
By Business Wire
May 26, 2021 6:59 AM EDT
PRESS RELEASES
Xencor And Bristol Myers Squibb Enter License Agreement For Use Of Xtend™ XmAb® Technology In SARS-CoV-2 Neutralizing Monoclonal Antibody Combination For The Treatment Of COVID-19
By Business Wire
May 25, 2021 8:01 AM EDT
PRESS RELEASES
Bristol Myers Squibb To Host Virtual Investor Event To Discuss ASCO 2021 Highlights
By Business Wire
May 25, 2021 6:59 AM EDT
PRESS RELEASES
Bristol Myers Squibb Presents New Data At Digestive Disease Week® On Zeposia (ozanimod) Highlighting Clinical Benefits And Safety Profile In Patients With Ulcerative Colitis
By Business Wire
May 23, 2021 11:35 AM EDT
PRESS RELEASES
U.S. Food And Drug Administration Approves Opdivo® (nivolumab) As Adjuvant Treatment Of Completely Resected Esophageal Or Gastroesophageal Junction Cancer In Patients Who Have Received Neoadjuvant Chemoradiotherapy
By Business Wire
May 20, 2021 1:26 PM EDT
PRESS RELEASES
Chief Of The Division Of Hematology And Medical Oncology, Weill Cornell Medicine And New York-Presbyterian/Weill Cornell Medical Center (Photo: Business Wire)
By Business Wire
May 20, 2021 6:59 AM EDT
INVESTING
Agenus Shares Blast Higher on Deal with Bristol Myers
By Dan Weil
May 18, 2021 12:14 PM EDT
PRESS RELEASES
Agenus And Bristol Myers Squibb Announce Exclusive Global License For Agenus' Anti-TIGIT Bispecific Antibody Program
By GlobeNewswire
May 18, 2021 7:30 AM EDT
PRESS RELEASES
Agenus And Bristol Myers Squibb Announce Exclusive Global License For Agenus' Anti-TIGIT Bispecific Antibody Program
By Business Wire
May 18, 2021 7:30 AM EDT
PRESS RELEASES
Bristol Myers Squibb To Take Part In UBS Global Healthcare Virtual Conference
By Business Wire
May 18, 2021 6:59 AM EDT
JIM CRAMER
Morning Bell With Jim Cramer: 4 Stocks to Watch
By Vidhi Choudhary
May 10, 2021 8:52 AM EDT
Video
4 Stocks Jim Cramer Is Watching Next Week
May 7, 2021 2:22 PM EDT
PRESS RELEASES
DarwinHealth Announces A Research Collaboration With Bristol Myers Squibb For A Novel Cancer Target Discovery (NCTI) Initiative
By PR Newswire
May 6, 2021 8:03 AM EDT
PRESS RELEASES
Bristol Myers Squibb To Take Part In The 2021 Bank Of America Securities Health Care Conference
By Business Wire
May 5, 2021 6:59 AM EDT
JIM CRAMER
Cramer's Mad Money Recap: Cleveland-Cliffs, Goodyear, FedEx
By Scott Rutt
May 4, 2021 8:17 PM EDT
PRESS RELEASES
Bristol Myers Squibb Presents New Clinical And Real-World Data On Mavacamten And Obstructive Hypertrophic Cardiomyopathy At Upcoming American College Of Cardiology's 70th Annual Scientific Session
By Business Wire
May 3, 2021 9:11 AM EDT
INVESTING
Premarket Movers Thursday - Facebook, Apple, Twitter
By Vidhi Choudhary
Apr 29, 2021 8:39 AM EDT
